Picture of Sangui Biotech International logo

SGBI Sangui Biotech International Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Sangui Biotech International, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0210.0270.0150.030.03
Net Total Accounts Receivable
Net Total Receivables0.0580.0420.020.0250.025
Prepaid Expenses
Total Current Assets0.1020.0790.0490.0670.068
Net Property, Plant And Equipment000.0770.0670.063
Total Assets0.1020.0790.1250.1340.131
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.4530.6710.7910.9550.936
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities-0.1690.030.2080.3580.37
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity0.2710.049-0.083-0.224-0.239
Total Liabilities & Shareholders' Equity0.1020.0790.1250.1340.131
Total Common Shares Outstanding